These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

402 related items for PubMed ID: 19893355

  • 1. Detection of isoniazid and rifampicin resistance by sequencing of katG, inhA, and rpoB genes in Korea.
    Cho EH, Bae HK, Kang SK, Lee EH.
    Korean J Lab Med; 2009 Oct; 29(5):455-60. PubMed ID: 19893355
    [Abstract] [Full Text] [Related]

  • 2. Molecular characteristics of rifampin and isoniazid resistant Mycobacterium tuberculosis strains from Beijing, China.
    Jiao WW, Mokrousov I, Sun GZ, Li M, Liu JW, Narvskaya O, Shen AD.
    Chin Med J (Engl); 2007 May 05; 120(9):814-9. PubMed ID: 17531124
    [Abstract] [Full Text] [Related]

  • 3. Mutations of rpoB, katG, inhA and ahp genes in rifampicin and isoniazid-resistant Mycobacterium tuberculosis in Kyrgyz Republic.
    Isakova J, Sovkhozova N, Vinnikov D, Goncharova Z, Talaibekova E, Aldasheva N, Aldashev A.
    BMC Microbiol; 2018 Mar 22; 18(1):22. PubMed ID: 29566660
    [Abstract] [Full Text] [Related]

  • 4. Use of smear-positive samples to assess the PCR-based genotype MTBDR assay for rapid, direct detection of the Mycobacterium tuberculosis complex as well as its resistance to isoniazid and rifampin.
    Somoskovi A, Dormandy J, Mitsani D, Rivenburg J, Salfinger M.
    J Clin Microbiol; 2006 Dec 22; 44(12):4459-63. PubMed ID: 17035488
    [Abstract] [Full Text] [Related]

  • 5. High-resolution melting curve analysis for rapid detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis clinical isolates.
    Choi GE, Lee SM, Yi J, Hwang SH, Kim HH, Lee EY, Cho EH, Kim JH, Kim HJ, Chang CL.
    J Clin Microbiol; 2010 Nov 22; 48(11):3893-8. PubMed ID: 20844231
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of the GenoType MTBDRplus assay for rifampin and isoniazid susceptibility testing of Mycobacterium tuberculosis strains and clinical specimens.
    Hillemann D, Rüsch-Gerdes S, Richter E.
    J Clin Microbiol; 2007 Aug 22; 45(8):2635-40. PubMed ID: 17537937
    [Abstract] [Full Text] [Related]

  • 7. Detection of rpoB, katG and inhA gene mutations in Mycobacterium tuberculosis clinical isolates from Chongqing as determined by microarray.
    Yao C, Zhu T, Li Y, Zhang L, Zhang B, Huang J, Fu W.
    Clin Microbiol Infect; 2010 Nov 22; 16(11):1639-43. PubMed ID: 20491829
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Detection of genomic mutations in katG, inhA and rpoB genes of Mycobacterium tuberculosis isolates using polymerase chain reaction and multiplex allele-specific polymerase chain reaction.
    Khosravi AD, Goodarzi H, Alavi SM.
    Braz J Infect Dis; 2012 Nov 22; 16(1):57-62. PubMed ID: 22358357
    [Abstract] [Full Text] [Related]

  • 10. [Evaluation of the genotype MTBDR assay for rapid detection of rifampin and isoniazid resistance in clinical Mycobacterium tuberculosis complex clinical isolates].
    Aslan G, Tezcan S, Emekdaş G.
    Mikrobiyol Bul; 2009 Apr 22; 43(2):217-26. PubMed ID: 19621606
    [Abstract] [Full Text] [Related]

  • 11. Study of rifampicin and isoniazid resistance mutation genes of M. tuberculosis isolates in Nepal.
    Khadka JB, Rai SK, Shrestha S, Maharjan B, Bhatta DR, Ghimire P.
    Nepal Med Coll J; 2011 Sep 22; 13(3):147-51. PubMed ID: 22808802
    [Abstract] [Full Text] [Related]

  • 12. Genotypic analysis of isoniazid and rifampin resistance in drug-resistant clinical Mycobacterium tuberculosis complex isolates in southern Turkey.
    Aslan G, Tezcan S, Serin MS, Emekdas G.
    Jpn J Infect Dis; 2008 Jul 22; 61(4):255-60. PubMed ID: 18653964
    [Abstract] [Full Text] [Related]

  • 13. The mutations of katG and inhA genes of isoniazid-resistant Mycobacterium tuberculosis isolates in Taiwan.
    Tseng ST, Tai CH, Li CR, Lin CF, Shi ZY.
    J Microbiol Immunol Infect; 2015 Jun 22; 48(3):249-55. PubMed ID: 24184004
    [Abstract] [Full Text] [Related]

  • 14. Molecular mechanism of rifampicin and isoniazid resistance in Mycobacterium tuberculosis from Bangladesh.
    Rahim Z, Nakajima C, Raqib R, Zaman K, Endtz HP, van der Zanden AG, Suzuki Y.
    Tuberculosis (Edinb); 2012 Nov 22; 92(6):529-34. PubMed ID: 22863574
    [Abstract] [Full Text] [Related]

  • 15. Rapid detection of specific gene mutations associated with isoniazid or rifampicin resistance in Mycobacterium tuberculosis clinical isolates using non-fluorescent low-density DNA microarrays.
    Aragón LM, Navarro F, Heiser V, Garrigó M, Español M, Coll P.
    J Antimicrob Chemother; 2006 May 22; 57(5):825-31. PubMed ID: 16547071
    [Abstract] [Full Text] [Related]

  • 16. Occurrence of disputed rpoB mutations among Mycobacterium tuberculosis isolates phenotypically susceptible to rifampicin in a country with a low incidence of multidrug-resistant tuberculosis.
    Al-Mutairi NM, Ahmad S, Mokaddas E, Eldeen HS, Joseph S.
    BMC Infect Dis; 2019 Jan 03; 19(1):3. PubMed ID: 30606116
    [Abstract] [Full Text] [Related]

  • 17. Characterization of mutations causing rifampicin and isoniazid resistance of Mycobacterium tuberculosis in Syria.
    Madania A, Habous M, Zarzour H, Ghoury I, Hebbo B.
    Pol J Microbiol; 2012 Jan 03; 61(1):23-32. PubMed ID: 22708343
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Conventional and molecular diagnosis in a group of patients with drug-resistant tuberculosis].
    Mindru R, Spînu V, Popa C, Botezatu E, Spătaru R.
    Pneumologia; 2014 Jan 03; 63(3):168-73. PubMed ID: 25420292
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.